Intracranial Therapeutic Delivery Market revenue will climb to US$ 4.2 Bn by the end of 2032 – Persistence Market Research
August 08, 2022 10:00 ET
|
Persistence Market Research
New York, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The global intracranial therapeutic delivery market is currently valued at around US$ 1.6 Bn and is anticipated to progress at an impressive CAGR of 7.9%...
Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
November 03, 2021 10:00 ET
|
Lynx Biosciences, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today announced the successful closing of its Series Seed Preferred Stock...